Sana Biotechnology Inc reports results for the quarter ended in December - Earnings Summary

Sana Biotechnology

16/03/2023 21:07

* Sana Biotechnology Inc  SANA.OQ  reported a quarterly
adjusted
loss of 38 cents​​ per share for the quarter ended in December.
The mean expectation of three analysts for the quarter was for a
loss of 51 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Sana Biotechnology Inc's reported EPS for the quarter was
a loss
of 42 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Sana Biotechnology Inc shares had fallen by 13.4% this
quarter.
    * The company reported a quarterly loss of $80.44 million.
    * Wall Street's median 12-month price target for Sana
Biotechnology Inc is $9.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 16 at 09:07 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.51          -0.38          Beat
 Sep. 30 2022      -0.53          -0.45          Beat
 Jun. 30 2022      -0.51          -0.39          Beat
 Mar. 31 2022      -0.47          -0.47          Met